Scilex Holding (SCLX) Accounts Payables (2021 - 2026)

Scilex Holding (SCLX) posted quarterly Accounts Payables of $101.6 million for Q1 2026, up 77.41% year-over-year from $57.3 million in Q1 2025, and up 17.75% on a QoQ basis from $86.3 million in Q4 2025.

Scilex Holding (SCLX) Accounts Payables (2021 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Accounts Payables for 6 consecutive years, with $101.6 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Accounts Payables rose 77.41% year-over-year to $101.6 million; the TTM figure through Mar 2026 stood at $101.6 million (up 77.41% YoY), while the FY2025 annual figure was $86.3 million, up 63.94% from the prior year.
  • Accounts Payables came in at $101.6 million for Q1 2026 at Scilex Holding, up from $86.3 million in the prior quarter.
  • The five-year high for Accounts Payables was $101.6 million in Q1 2026, with the low at $41003.0 in Q1 2022.
  • Average Accounts Payables over 5 years is $30.7 million, with a median of $9.8 million recorded in 2023.
  • Across the five-year window, Accounts Payables sank 98.16% in 2022 and soared 53473.08% in 2024, its largest moves.
  • Year by year, Accounts Payables stood at $79000.0 in 2022, then jumped by 254.43% to $280000.0 in 2023, then surged by 18692.86% to $52.6 million in 2024, then soared by 63.94% to $86.3 million in 2025, then increased by 17.75% to $101.6 million in 2026.
  • According to Business Quant data, Accounts Payables over the past three periods registered $101.6 million, $86.3 million, and $67.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 5.03 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 10.46 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 33.77 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -22.51 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 3.86 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 2.94 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 645.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 4.51 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn 101.58 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 101.58 Mn
Dec 31, 2025 86.27 Mn
Sep 30, 2025 67.36 Mn
Jun 30, 2025 59.16 Mn
Mar 31, 2025 57.26 Mn
Dec 31, 2024 52.62 Mn
Sep 30, 2024 346,000.00
Jun 30, 2024 41.79 Mn
Mar 31, 2024 42.22 Mn
Dec 31, 2023 280,000.00
Sep 30, 2023 2.04 Mn
Jun 30, 2023 78,000.00
Mar 31, 2023 9.82 Mn
Dec 31, 2022 79,000.00
Sep 30, 2022 809,292.00
Jun 30, 2022 598,646.00
Mar 31, 2022 41,003.00
Dec 31, 2021 4.28 Mn
Sep 30, 2021 43,569.00
Jun 30, 2021 20,025.00